Opioid Lawsuit – Government Settlements with Manufacturers & Sellers
Opioid Lawsuit Header Opioid Lawsuit Header

It’s estimated that more than 55,000 Americans die each year from a drug overdose, which has become the leading cause of death of individuals under the age of 50. Sixty percent of these deaths are caused by opioids. The jump in fatalities over the past 15 years has been staggering, a more than three-times increase.

In addition to the devastating toll this epidemic is taking on the addicts, family and friends, the monetary cost to governmental agencies is in the tens of billions of dollars each year when considering public healthcare, treatment facilities, law enforcement, criminal justice and jail expenses. The United States Centers for Disease Control and Prevention estimates the cost is approximately $75 billion per year.

Our law firm is currently representing more than 450 governmental agencies against wholesale distributors and manufacturers of opioids in order to recover the immense damages they have sustained as a result of these companies creating the current opioid epidemic. The cases are pending in the Northern District of Ohio before Judge Dan Polster.

We only represent governments. We do not represent individuals impacted by the callous and fraudulent actions of these companies.

 

Why are States, Counties & Cities Suing Opioid Distributors & Manufacturers

Reasons for Government Opioid Litigation

Hundreds of governmental entities have begun the process of suing wholesale distributors and manufacturers of opioids seeking reimbursement for government spending arising out of opioid addictions and overdoses.

The defendants often include companies such as McKesson Corporation, Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, and Covidien.

The complaints typically allege the wholesale distributors violated the federal Controlled Substances Act by failing to alert the U.S. Drug Enforcement Administration of suspicious opioids purchases, such as orders of unusual size, frequency or pattern. The claims against the manufacturers are based on allegations the companies exaggerated the benefits of the medication and knew the drugs were being overly prescribed, yet failed to warn doctors of the extremely addictive nature of the narcotics and the need to strictly limit the dose.

The lawsuits also claim the pharmaceutical companies lobbied politicians and doctors in an effort to artificially increase the use of opioids, and willfully allowed the drugs to enter the black market. For example, in 2012, there were 793 million doses of opioids prescribed in Ohio, which is 60-times larger than the entire population of the state. In 2010, 254 million prescriptions for opioids were filled in the United States, which amount was capable of treating every adult in the country 24-hours a day for one month.

Read More

Claims against Purdue additionally include allegations of fraud and knowingly encouraging addiction. Lawyers assert the company promoted its drug OxyContin to the FDA and medical community as less addictive than other painkillers, claiming it would last for 12 hours. This was not correct. The painkiller would last less than 12 hours, which means the user would begin to experience withdrawals, which would then cause them to become dependent on the drug. It’s the process of withdrawing that often leads to the actual addiction, as the user feels the need to reduce the withdrawal pain.

In 2007, Purdue pleaded guilty to the federal crime of misbranding its drug OxyContin "with intent to defraud and mislead the public." Purdue paid a fine of $635 million. Purdue received FDA approval to sell OxyContin in 1995. In 1996, it sold $45 million worth, but then went on a national campaign to convince doctors that it was a non-addictive pain reliever, and their campaign worked. By 2002, the company was selling $1.5 billion worth of OxyContin each year. By 2012, this number had risen to $3 billion, with primary-care doctors (rather than specialists) being responsible for approximately half of the prescriptions.

Over the past decade, pharmaceutical companies have spent more than $880 million lobbying at the state and federal level in an effort to push legislation and regulations regarding opioids. Incredibly, the opioid lobbying has been eight times greater than that of the gun lobby.

 

Damages Being Sought in Government Opioid Claims

government opioid compensation

Government agencies are seeking reimbursement for some of the health and social costs related to opioid abuse, which is estimated to be in excess of $55 billion each year.

Some of the specific damages being sought include:

  1. Building and maintaining treatment facilities.
  2. Reimbursement of Medicaid and other governmental expenses related to the treatment of addicts, including the payment for unnecessarily prescribed opioids, and the antidote to treat overdoses.
  3. Reimbursement for added law enforcement and medical personnel to treat the opioid epidemic.
  4. Reimbursement for costs of prosecutions and jails.
 

Opioid Litigation Videos

Watch More Videos
 

Government Settlements with Opioid Wholesale Distributors & Manufacturers

In 2017, McKesson Corporation, one of the nation’s largest distributors of pharmaceuticals, paid a $150 million civil penalty for violations of the Controlled Substances Act. McKesson was failing to report “suspicious orders” for oxycodone and hydrocodone, such as orders that were suspicious in frequency, size, or other patterns. To read more, click Justice Department McKesson

In 2017, Mallinckrodt Plc, a manufacturer of oxycodone, agreed to pay $35 million to resolve U.S. investigations into its monitoring and reporting of suspicious orders of controlled substances. To read more, click Reuters

In 2017, Costco Wholesale reached an $11.75 million settlement to resolve allegations that its pharmacies violated the Controlled Substances Act when they improperly filled prescriptions for controlled substances. To read more, click Justice Department Cosco

In 2017, Cardinal Health reached a settlement in the amount of $20 million with the state of West Virginia regarding the company's distribution of opioids in state between 2007 and 2012. "Cardinal and other wholesalers in a six-year period sent 780 million hydrocodone and oxycodone pills to West Virginia – 433 per state resident . . . . In that time, there were 1,728 fatal overdoses from the addictive painkillers.” To read more, click Columbus Business First

In 2016, Cardinal Health, Inc. agreed to pay $44 million to the United States to resolve allegations that it violated the Controlled Substances Act in Maryland, Florida and New York by failing to report suspicious orders of controlled substances to pharmacies located in those states. To read more, click Justice Department Cardinal Health

In 2015, Purdue Pharma, the maker of OxyContin, agreed to pay the state of Kentucky $24 million to settle a lawsuit accusing the company of misleading the public about the addictiveness of the prescription opioid. To read more, click CBS News

 

The Human Side of the Opioid Epidemic

an opioid addict

Approximately 2 million Americans are currently addicted to opioids, with more than 90 million Americans having used a prescription painkiller in the past year. The most commonly used are hydrocodone (such as Vicodin, Lorcet & Lortab), Oxycodone (such as OxyContin, Percodan & Roxicet), methadone, fentanyl and morphine.

The number one opioid killer appears to be fentanyl or an analog (variation), especially when it is combined with heroin or cocaine. Fentanyl is 50 to 100 times more potent than morphine, and 30 to 50 times more potent than heroin. One fentanyl analog, Carfentanil, is 5,000 times stronger than heroin. An amount as small as a few drops of sand can be fatal. The drug is so powerful that even when numerous doses of the antidote naloxone (Narcan) are timely administered, the person will be lucky to survive.

The picture of the homeless man living on the streets is not the accurate portrayal of the modern-day addict. Instead, the portrait is one of individuals of all ages, race, ethnicity, education and socioeconomic status. White, working-class, individuals living in rural areas make up one the largest subset of deaths.

Read More

One of the common cycles involving heroin addiction is the user begins his/her use consuming painkillers. Once the user becomes dependent on the high, and especially when experiencing withdrawal symptoms, the user looks for other ways to achieve the result without the costs of prescription opioids. This is when the user switches to heroin, which is more potent and cheaper than FDA approved opioids. Eighty percent of heroin users started out misusing medically prescribed opioids.

 

Opioid Lawsuit News

News Banner

Can This Judge Solve the Opioid Crisis?

Judge Dan Aaron Polster of the Northern District of Ohio has perhaps the most daunting legal challenge in the country: resolving more than 400 federal lawsuits brought by cities, counties and Native American tribes against central figures in the national opioid tragedy, including makers of the prescription painkillers, companies that distribute them, and pharmacy chains that sell them. And he has made it clear that he will not be doing business as usual. To read more, click New York Times

Opioid crisis: justice department to back local lawsuits against manufacturers

A new federal taskforce will target misdeeds of opioid manufacturers and distributors, and the US Department of Justice will back lawsuits brought by local governments against makers of the prescription painkillers at the root of the opioids public health crisis, the attorney general, Jeff Sessions, announced on Tuesday. To read more, click The Guardian

Plaintiff Lawyers See Nationwide Settlement As Only End For Opioid Lawsuits

Lawyers meeting in a federal courtroom in Cleveland today to discuss a settlement of opioid litigation face the difficult task of crafting a deal that will not only pay their clients -- mostly towns and cities -- but include states and even the federal government while spreading the cash evenly across the country. To read more, click Forbes

Read More

The ‘forgotten people’ of the opioid epidemic

Members of the Seneca Nation of Indians and others from the surrounding western New York community gathered together in mourning. They rang a bell and lit lanterns, symbols of loved ones affected by the opioid epidemic. The bell tolled dozens of times, honoring the dead. To read more, click The Hill

Ex-DEA agent: Opioid crisis fueled by drug industry and Congress

Whistleblower Joe Rannazzisi says drug distributors pumped opioids into U.S. communities -- knowing that people were dying -- and says industry lobbyists and Congress derailed the DEA's efforts to stop it. To read more, click 60 Minutes Investigation

Lawyers Hope to Do to Opioid Makers What They Did to Big Tobacco

Attorneys general who use outside lawyers say a contingent-fee arrangement can help them pursue worthwhile litigation they haven’t the resources to mount alone. In most such arrangements, outside law firms bear the cost of the litigation and are paid only if it succeeds. More than 300,000 Americans have died of opioid overdoses since the late 1990s, according to the Centers for Disease Control and Prevention. Many public-health officials maintain that aggressive pharmaceutical-company marketing and lax prescribing helped cause addiction that for many people progressed to heroin and other illicit drugs. To read more, click Wall Street Journal

Opioid makers gave millions to patient advocacy groups to sway prescribing

As the nation grapples with a worsening opioid crisis, a new report suggests that drug makers provided substantial funding to patient advocacy groups and physicians in recent years in order to influence the controversial debate over appropriate usage and prescribing. To read more, click STAT - Advocacy Payments

Opioid makers face hundreds of lawsuits for misleading doctors about drug’s addictive nature

“About 150 Americans are going to die today, just today, while we’re meeting,” U.S. District Judge Dan Polster of Cleveland, Ohio, told the parties earlier this month. “And in my humble opinion, everyone shares some of the responsibility, and no one has done enough to abate it.” He sees no value in depositions and trials, he said. “People aren’t interested in figuring out the answer to interesting legal questions like pre-emption and learning intermediary, or unraveling complicated conspiracy theories.” Instead, “my objective is to do something meaningful to abate this crisis and to do it in 2018,” the judge said. To read more, click USA Today

STAT forecast: Opioids could kill nearly 500,000 Americans in the next decade

Even the more middle-of-the-road forecasts suggest that by 2027, the annual U.S. death toll from opioids alone will likely surpass the worst year of gun deaths on record, and may top the worst year of AIDS deaths at the peak of that epidemic in the 1990s, when nearly 50,000 people were dying each year. The average toll across all 10 forecasts: nearly 500,000 deaths over the next decade. Beyond the immeasurable pain to families, the overdoses will cost the U.S. economy hundreds of billions of dollars. To read more, click STAT

Drug Deaths in America Are Rising Faster Than Ever

Drug overdose deaths in 2016 most likely exceeded 59,000, the largest annual jump ever recorded in the United States. . . . The death count is the latest consequence of an escalating public health crisis, now made more deadly by an influx of illicitly manufactured fentanyl and similar drugs. To read more, click New York Times

U.S. state, local government lawsuits over opioids face uphill battle

A growing number of U.S. states, counties and cities are filing lawsuits accusing drug companies for deceptively marketing opioid painkillers to downplay their addictiveness. To read more, click Reuters

Pharma lobbying held deep influence over opioid policies

The opioid industry and its allies contributed to roughly 7,100 candidates for state-level offices. For over a decade, a group called the Pain Care Forum has met with some of the highest-ranking health officials in the federal government, while quietly working to influence proposed regulations on opioids and promote legislation and reports on the problem of untreated pain. The group is coordinated by the chief lobbyist for Purdue Pharma, the maker of OxyContin. To read more, click Center for Public Integrity

A mega-case puts opioids on trial

A state judge will decide whether Mississippi Attorney General Jim Hood can proceed with a suit against opioid manufacturers in which the companies stand accused of promoting the drugs by allegedly systematically understating their health risks and exaggerating their benefits, violating state law. To read more, click Washington Post

Are Pharmaceutical Companies to Blame for the Opioid Epidemic?

Ohio’s Attorney General Mike DeWine filed a lawsuit against a handful of pharmaceutical companies accusing them of spending millions on marketing campaigns that “trivialize the risks of opioids while overstating the benefits of using them for chronic pain.” The companies, the lawsuit alleges, lobbied doctors to influence their opinions about the safety of opioids. To read more, click The Atlantic

OxyContin: Purdue Pharma’s painful medicine

It estimated that "nonmedical use of prescription painkillers costs health insurers up to $72.5 billion annually in direct health care costs." Opioids generated $11 billion in revenues for pharmaceutical companies, says market research firm Frost & Sullivan. To read more, click Fortune

FDA to Drugmaker: Yank Opioid Opana ER from Market

The FDA has asked Endo Pharmaceuticals to stop selling its extended-release painkiller, Opana ER, after concluding the drug's risks outweigh its benefits. It's the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market. The agency said it has seen a "significant shift" from people crushing and snorting Opana ER to get high to injecting it. To read more, click CBS News

America's opioid epidemic

This CBS site provides a comprehensive list of all the stories CBS has done on the opioid epidemic. To view, click CBS News Opioid Epidemic

For additional news stories, click Levin Opioids News

 
Why Choose Us

Our law firm is currently representing more than 450 governmental agencies against wholesale distributors and manufacturers of opioids in order to recover the immense damages they have sustained as a result of these companies creating the current opioid epidemic. We only represent governments. We do not represent individuals impacted by the callous and fraudulent actions of these companies.

We are one of only a very few law firms that have been appointed to the Plaintiffs Executive Committee by the judge overseeing the government actions against the opioid manufacturers and distributors. This means that we are directly involved in the national investigation and discovery against these companies that will hopefully result in a positive outcome for the governments who have been paying the costs of this epidemic.

We have been in business for more than 60 years, and we are seen as a national leader in this type of litigation. We are the law firm that formulated the idea of rewriting Florida’s Medicaid Third-Party Recovery Act, and then initiating the litigation against the Tobacco Industry on behalf of the state of Florida, which resulted in a $13 billion settlement.

Professor Richard Daynard of Northeastern University stated that our law firm’s rewrite of Florida’s Medicaid bill for the purpose of suing Big Tobacco was: "the single biggest blow against the tobacco industry and for the public health that's ever been done in the United states."

We are the founder of Mass Torts Made Perfect, which is a national seminar attended by approximately 800 lawyers twice per year where we help teach the successful handling of cases against the world’s largest pharmaceutical companies.

For more information, please visit our About Us section.